Baldwin Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,328
| Closed | -$363K | – | 201 |
|
|
2024
Q3 | $363K | Hold |
2,328
| – | – | 0.05% | 174 |
|
|
2024
Q2 | $363K | Sell |
2,328
-50
| -2% | -$7.52K | 0.05% | 166 |
|
|
2024
Q1 | $322K | Sell |
2,378
-100
| -4% | -$13.2K | 0.04% | 181 |
|
|
2023
Q4 | $334K | Hold |
2,478
| – | – | 0.05% | 166 |
|
|
2023
Q3 | $336K | Sell |
2,478
-50
| -2% | -$6.83K | 0.06% | 154 |
|
|
2023
Q2 | $362K | Hold |
2,528
| – | – | 0.06% | 157 |
|
|
2023
Q1 | $351K | Hold |
2,528
| – | – | 0.06% | 162 |
|
|
2022
Q4 | $343K | Hold |
2,528
| – | – | 0.06% | 158 |
|
|
2022
Q3 | $277 | Sell |
2,528
-100
| -4% | -$12.7K | 0.06% | 176 |
|
|
2022
Q2 | $347 | Sell |
2,628
-300
| -10% | -$39.4K | 0.07% | 173 |
|
|
2022
Q1 | $388 | Sell |
2,928
-25
| -0.8% | -$3K | 0.06% | 181 |
|
|
2021
Q4 | $344 | Hold |
2,953
| – | – | 0.05% | 192 |
|
|
2021
Q3 | $355K | Buy |
2,953
+25
| +0.9% | +$2.91K | 0.06% | 191 |
|
|
2021
Q2 | $351K | Hold |
2,928
| – | – | 0.06% | 196 |
|
|
2021
Q1 | $291K | Hold |
2,928
| – | – | 0.05% | 206 |
|
|
2020
Q4 | $293K | Sell |
2,928
-50
| -2% | -$5.3K | 0.06% | 192 |
|
|
2020
Q3 | $326K | Hold |
2,978
| – | – | 0.08% | 154 |
|
|
2020
Q2 | $315K | Hold |
2,978
| – | – | 0.1% | 121 |
|
|
2020
Q1 | $266K | Hold |
2,978
| – | – | 0.09% | 124 |
|
|
2019
Q4 | $297K | Hold |
2,978
| – | – | 0.08% | 137 |
|
|
2019
Q3 | $265K | Buy |
2,978
+128
| +4% | +$11.1K | 0.08% | 141 |
|
|
2019
Q2 | $235K | Buy |
2,850
+50
| +2% | +$3.92K | 0.07% | 152 |
|
|
2019
Q1 | $226K | Hold |
2,800
| – | – | 0.07% | 151 |
|
|
2018
Q4 | $213K | Buy |
2,800
+50
| +2% | +$3.9K | 0.07% | 150 |
|
|
2018
Q3 | $218K | Buy |
+2,750
| New | +$208K | 0.06% | 158 |
|
Other funds holding AZN
